Cargando…

Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model

Detalles Bibliográficos
Autores principales: Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504352/
http://dx.doi.org/10.1097/01.GOX.0000558321.87208.c1
_version_ 1783416559319908352
author Swearingen, Bruce J.
Graves, Scott S.
Storb, Rainer
Mathes, David W.
author_facet Swearingen, Bruce J.
Graves, Scott S.
Storb, Rainer
Mathes, David W.
author_sort Swearingen, Bruce J.
collection PubMed
description
format Online
Article
Text
id pubmed-6504352
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65043522019-05-29 Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model Swearingen, Bruce J. Graves, Scott S. Storb, Rainer Mathes, David W. Plast Reconstr Surg Glob Open PSRC 2019 Abstract Supplement Wolters Kluwer Health 2019-04-29 /pmc/articles/PMC6504352/ http://dx.doi.org/10.1097/01.GOX.0000558321.87208.c1 Text en Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC 2019 Abstract Supplement
Swearingen, Bruce J.
Graves, Scott S.
Storb, Rainer
Mathes, David W.
Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
title Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
title_full Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
title_fullStr Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
title_full_unstemmed Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
title_short Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
title_sort abstract 47: amd3100 (plerixafor) as a single-dose stem cell mobilizing agent in vascularized composite tissue allograft (vca) transplantation in a canine dla-mismatch model
topic PSRC 2019 Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504352/
http://dx.doi.org/10.1097/01.GOX.0000558321.87208.c1
work_keys_str_mv AT swearingenbrucej abstract47amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninedlamismatchmodel
AT gravesscotts abstract47amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninedlamismatchmodel
AT storbrainer abstract47amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninedlamismatchmodel
AT mathesdavidw abstract47amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninedlamismatchmodel